Saccharomyces cerevisiae MMS2 encodes a ubiquitin-conjugating enzyme variant, belongs to the error-free branch of the RAD6 postreplication repair (PRR) pathway, and is parallel to the REV3-mediated mutagenesis branch. A mutation in genes of either the MMS2 or the REV3 branch does not result in extreme sensitivity to DNA damaging agents; however, deletion of both subpathways of PRR results in a synergistic phenotype. Nevertheless, the double mutant is not as sensitive to DNA damaging agents as a rad6 or rad18 mutant defective in the entire PRR pathway, suggesting an additional subpathway within PRR. A synthetic lethal screen was employed in the presence of a sublethal dose of a DNA damaging agent to identify novel genes involved in PRR, which resulted in the isolation of RAD9 as a candidate PRR gene.
INTRODUCTION
Eukaryotic cells are constantly challenged by environmental stresses and endogenous cellular processes that can cause DNA damage and compromise the integrity of the genome.
Organisms have evolved surveillance mechanisms that sense and respond to DNA damage.
These surveillance mechanisms, known as DNA-damage checkpoints, were initially identified when inactivation of genes resulted in defects in cell cycle arrest in response to genotoxic treatments.
The DNA damage checkpoint was initially discovered by WEINERT and HARTWELL (1988) when analyzing the rad9 mutant of Saccharomyces cerevisiae. In addition to RAD9 several genes have been found to be involved in the DNA damage response pathway. The G1, G2 and intra-S DNA damage checkpoints encompass several groups of proteins that function in combination with a central signal transduction cascade. Rad17, Mec3 and Ddc1 form a heterotrimeric complex with a structural similarity to proliferating cell nuclear antigen (PCNA) (KONDO et al. 1999; MELO et al. 2001; THELEN et al. 1999) . Rad24 is related to replication factor C (RFC), a protein complex responsible for loading PCNA onto DNA during replication (WAGA and STILLMAN 1998) . The interaction of Rad24 with the four smaller RFC subunits acts to load the Rad17-Mec3-Ddc1 complex to sites of DNA damage (KONDO et al. 2001; MAJKA and BURGERS 2003; MELO et al. 2001) . Once the damage has been detected, the checkpoint pathway transmits the signal through a kinase cascade.
The RAD9 gene functions predominantly in the G1/S and G2/M transitions of the DNA damage checkpoints (SIEDE et al. 1993) . Rad9 is phosphorylated during normal cell-cycle progression (VIALARD et al. 1998) , and hyperphosphorylated after DNA damage in a Mec1-and Tel1-dependent manner (EMILI 1998; VIALARD et al. 1998) . It is proposed that Rad9 recruits affect the growth of the single mutant, but will effectively kill the double mutants. One of the mutations identified in this screen revealed a role for checkpoint proteins in the PRR pathway.
We report here the synergistic interaction of rad9 with PRR mutations. Our results show the partial requirement of RAD9 in the mutagenesis observed in the mms2∆ mutants. These findings suggest a role for the checkpoint pathway in PRR, potentially for delaying the cell cycle and allowing time for the cells to tolerate the damage via the PRR pathway.
MATERIALS AND METHODS

Yeast strains and cell culture:
The yeast strains used in this study are listed in Table 1 .
All the strains are isogenic derivatives of DBY747, originally obtained from Dr. D. Botstein (Stanford University), HK578-10A and HK578-10D, obtained from Dr. H. Klein (New York University), or BY4741. BY4741 and its gene deletion derivatives were created by the Saccharomyces Genome Deletion Project consortium and purchased from Research Genetics (Invitrogen, Carlsbad, CA).
Yeast cells were cultured at 30 o C in either a rich YPD medium or a synthetic glucose (SD) medium supplemented with various nutrients as instructed (SHERMAN et al. 1983) . Intact yeast cells were transformed by a modified lithium acetate method (ITO et al. 1983) . For onestep targeted gene disruption (ROTHSTEIN 1983) , plasmid DNA containing the desired disruption cassette was cleaved with restriction enzymes prior to yeast transformation. Source and use of rad9∆::hisG-URA3-hisG (SCHIESTL et al. 1989 ), rad17∆::HIS3 (ZHU and XIAO 1998 ), rad18∆::TRP1 (XIAO et al. 1996 ), rad18∆::LEU2 (XIAO et al. 2000 , rev3∆::LEU2 (XIAO et al. 1996) and rev3∆:: hisG-URA3-hisG (ROCHE et al. 1994 ) are as described. The mms2∆::HIS3 and mms2∆::TRP1 disruption cassettes were produced using a PCR method. The plasmid pJJ215 (HIS3) or pJJ248 (TRP1) (JONES and PRAKASH 1990) was amplified using the primers YGL87 (5'-TTCTTATTCTGTATATGCAACGTAGAAGAAGCAGCCGTTTACACAAACAGCTATGAC CATG-3') and YGL88 (5'-GTGGCTTGGAATGCTGCAAATACTGTTTAGGAAAAAGTAGATAACGTTTTCCCAGTC ACGAC-3'). The PCR products contained the 5' and 3' flanking sequences of the MMS2
(underlined) open reading frame disrupted by HIS3 or TRP1, respectively. Synthetic sesitivity screen: Yeast cells (WXY1228) harboring the pSLS-based plasmids (BARBOUR et al. 2000) were grown overnight in 10 ml of SD medium lacking uracil. The cells were harvested by centrifugation, resuspended in the same volume of YPD medium, and incubated for another four hours. The cells were collected, washed twice in 50 mM potassium phosphate buffer (pH7.5) and resuspended in 10 ml of the same buffer. Ethyl methanesulfonate was added to a final concentration of 3% and the culture was incubated at 30 o C for 30 minutes.
10% filter-sterilized sodium thiosulfate was added to stop the reaction. The cells were washed twice, diluted and plated onto YPD or YPGal medium, and incubated for four days at 30 o C.
Individual non-sectoring colonies were picked and further characterized by two steps. First, they were streaked onto the same medium to monitor color segregation. Cells from the non-sectoring colonies were then used to inoculate 2 mls of liquid YPD. After an overnight incubation, cells were diluted and plated onto YPD to record colony-color segregation. For a synthetic sensitivity screen, cells were plated onto YPD containing 0.005% MMS.
Cell killing by DNA-damaging agents: MMS-and UV-induced liquid killing was performed as previously described (XIAO et al. 1996) . Briefly, overnight yeast cultures were used to inoculate fresh YPD at approximately 5x10 6 cells/ml and allowed to grow until the culture contained about 2x10 7 cells/ml. For MMS treatment, MMS was added to the culture at a final concentration as specified and aliquots were taken at given intervals. For UV treatment, cells were plated in duplicate at different dilutions and then exposed to 254 nm UV light in a UV crosslinker (Fisher Science model FB-UVXL-1000 at ~2400 mW/cm 2 ) at given doses in the dark. For γ-irradiation, cells were collected by centrifugation, resuspended in sterile water, exposed to γ-rays from a 60
Co γ-ray source at a dose rate of 22 rads/s and plated.
The gradient plate assay was performed as a semi-quantitative measurement of relative MMS sensitivity. 30 ml of molten YPD agar was mixed with the appropriate concentration of MMS to form the bottom layer. The gradient was created by pouring the media into tilted square petri dishes. After brief solidification for one hour, the petri dishes were returned flat and 30 ml of the same molten agar without MMS was poured to form the top layer. A 0.1 ml sample was taken from an overnight culture, mixed with 0.4 ml sterile water and 0.5 ml of molten YPD agar, and then immediately imprinted onto freshly made gradient plates via a sterile microscope slide.
Gradient plates were incubated at 30°C for the indicated time.
MMS sensitivity was also determined by a serial dilution assay. Yeast cells were inoculated in 3 ml of YPD medium (or selective medium if required) overnight and subcultured into 3 ml of fresh medium. Cells were incubated at 30 o C until a mid-logarithmic phase was reached. The cell density was adjusted to 2x10 6 cells/ml as determined by a hemocytometer, and further diluted serially 10-fold with ddH 2 O. The relative MMS sensitivity was determined using freshly made YPD plates containing the indicated amount of MMS. 5 µl aliquots of each dilution were applied onto YPD and YPD + MMS plates. The plates were incubated at 30 o C for 2 days and photographed. Synthetic genetic array and confirmation tests: Y8389 (rev1∆) and Y8426 (ubc13∆) were created by a non-essential gene switching method and crossed with the deletion mutant array as described (TONG et al. 2001) . The relevant diploids from the array were received from Dr. C. Boone (University of Toronto) and the random spore analysis was carried out as described (TONG et al. 2001 
RESULTS
Identification of synthetic sensitive mutations with mms2:
The synthetic lethal screen is a method of isolating novel mutants whose survival is dependent on the presence of the gene of interest. A colony-color based assay has been developed in the budding yeast (HIETER et al. 1985; KOSHLAND et al. 1985) , and we recently reported an improved method to enhance the screening efficiency (BARBOUR et al. 2000) . Here we wish to apply this method to the concept of a synthetic sensitiveity screen. It is well established that MMS2/UBC13 and REV1/3/7 represent two alternative branches for tolerance to many kinds of DNA damage (BROOMFIELD et al. 1998; XIAO et al. 1999) . Fig. 1A demonstrates that 0.005% MMS in the culture medium does not result in any noticeable lethal effect to the mms2 or rev3 single mutant; however, it completely inhibits the growth of the mms2 rev3 double mutant. Hence, mms2 and rev3 exhibit a strong synergistic interaction and the double mutant is inviable in the presence of 0.005% MMS.
Based on the above assertion and the hypothesis that novel genes may be identified whose mutation cause synergistic interactions with mms2/ubc13 and/or rev1/3/7, we adapted a synthetic lethal screen protocol to isolate mutations that are synergistic with mms2. This resulted in the isolation of mutations known to be synergistic with mms2 with respect to killing by MMS, such as rev1 and rev3, as well as novel mutations that do not belong to the above genes. One such mutant, SLM-11, displays a synergistic sensitivity on plates containing 0.005% MMS as compared to the mms2 single mutant (Fig. 1B) . To identify the gene whose mutation is responsible for the synergistic effect in SLM-11, a single-and a multi-copy yeast genomic library were screened for functional complementation of the MMS-sensitive phenotype found in SLM-11, which resulted in the isolation of RAD9. As shown by a reconstructed experiment (Fig.   1B ), SLM-11 transformed with a RAD9-containing plasmid restored the MMS resistance to a level comparable to that of the mms2 single mutant, whereas SLM-11 transformed with both RAD9 and MMS2 completely restored the MMS resistance to the wild type level. This result indicates that a rad9 mutation is synergistic with mms2 to killing by MMS. Note that SLM-11 transformed with MMS2 alone is expected to restore the MMS resistance to the rad9 single mutant level, which can be distinguished from that of wild type only at a higher MMS concentration (data not shown).
rad9 is synergistic with both mms2 and rev3: To ask whether RAD9 is the gene mutated in SLM-11 or an extragenic suppressor, we deleted RAD9 from an mms2∆ strain and examined the sensitivity of this double mutant relative to the corresponding single mutants. As shown in Fig. 2A , while the rad9∆ mutant showed little sensitivity and the mms2∆ single mutants showed slight sensitivity to the DNA-damaging agent, the rad9 mms2 double mutant was extremely sensitive to MMS. The effect of the two mutations was clearly synergistic as judged by a quantitative liquid killing assay (Fig. 2C ). To further prove that SLM-11 contains a rad9 mutation, we crossed SLM-11 with an mms2∆ rad9∆ mutant and performed random spore analysis. All 50 haploid spores analyzed displayed extreme sensitivity like SLM-11 or the mms2 rad9 double mutant, confirming that the unknown mutation in SLM-11 and RAD9 occupy the same chromosomal locus.
The synergistic interaction between mms2 and rad9 prompted us to look at the genetic interaction between RAD9 and another branch within the PRR pathway, namely, the mutagenesis pathway mediated by REV1/3/7. We combined rad9 with rev3 and determined the MMSinduced killing of the rad9 rev3 double mutant. Both single mutants alone showed no sensitivity on plates containing 0.005% MMS. To our surprise, the rad9 rev3 double mutant did not grow at all on the same MMS plate (Fig. 2B ). Quantitative analysis (Fig. 2D ) clearly indicates that the interaction is synergistic. These results suggest that the RAD9 gene genetically interacts with both the error-free and error-prone branches of PRR and may constitute a third branch of the PRR pathway.
RAD9 functions within the PRR pathway:
The synergistic interactions among rad9, mms2 and rev3 prompted us to ask whether the triple mutation is synergistic compared to each of the double mutations. The liquid killing experiment showed that the triple mutant is significantly more sensitive than the most sensitive double mutant mms2 rev3 (Fig. 3A) , suggesting a threebranch relationship represented by MMS2, REV3 and RAD9.
We have previously demonstrated that the mms2 rev3 double mutant is significantly less sensitive than the rad18 single mutant (BROOMFIELD et al. 1998) , and that the combination of any known mutations within the PRR branches did not reach the level of rad18 (XIAO et al. 2000 and data not shown). The level of MMS sensitivity of the mms2 rad9 rev3 triple mutant relative to the mms2 rev3 double mutant ( Fig. 3A) is reminiscent of the rad18 single mutant, which led us to speculate that RAD9 may function in the PRR pathway. To further determine the genetic involvement of RAD9 in the PRR pathway we combined the rad9 mutation with rad18 and compared the double mutant with other relevant mutants. The rad9 rad18 double mutant appears to be more sensitive than the rad18 single mutant in a liquid killing experiment (Fig. 3A ). We suspected that the increased MMS resistance of the rad18 single mutant was due to a high number of revertants as previously observed (XIAO et al. 1996) , possibly due to the acquisition of srs2 mutations capable of rescuing rad18 cells from killing by DNA-damaging agents (ABOUSSEKHRA et al. 1989; SCHIESTL et al. 1990 ). To partially overcome the above problem, we took freshly isolated individual colonies and performed liquid killing experiments including early time points (5 and 10 minutes). Indeed, within the first 10 minutes, the killing curves of rad18 and rad9 rad18 mutants were indistinguishable (Fig. 3A) . We further analyzed individual colonies survived after 40-minute MMS treatment and found that more than 86% (50 out of 58) of rad18 clones gained resistance to MMS, whereas none of rad9 rad18 survivors was resistant to MMS. We also cultured cells without MMS treatment and plated about 10 7 cells on plates containing various concentrations of MMS. On 0.001% MMS plates, rad18 cells formed about 8-fold more colonies than rad9 rad18 cells. Upon re-streaking these colonies, 43 out of 48 rad18 colonies inherited resistance, while none of 50 rad9 rad18 colonies displayed MMS resistance. This would explain most, if not all, observed difference between rad18 and rad9 rad18 cells in response to MMS treatment (Fig. 3A) . We also performed a gradient plate assay, which is able to distinguish individual revertants, and confirmed that indeed the rad9 rad18 double mutant is no more sensitive than the rad18 single mutant (Fig.3B , lanes 6 and 7), and that the rad9 mms2 rev3 triple mutant (lane 5) is only slightly less sensitive than the above two strains, while none of the above mutant strains displayed a growth defect in the absence of MMS (Fig. 3B) . Taken together, although we cannot formally rule out the possibility that differences in liquid killing (acute treatment) and plate-based assays (chronic treatment) also contribute to the above discrepancy, the above results generally support our hypothesis that RAD9 functions within the PRR pathway as the third branch independent of MMS2 and REV3, and that RAD18 is epistatic to all of the above three branches.
RAD9 is partially required for mutagenesis: It has been previously determined that PRR is composed of an error-free branch and an error-prone branch with characteristic phenotypes of spontaneous and damage-induced mutagenesis (BROOMFIELD et al. 1998; XIAO et al. 1999) . The effects of RAD9 deletion on mutagenesis were determined and compared with other relevant mutants using the trp1-289 reversion assay, which detects primarily base-pair substitutions. As expected, the mms2 single mutant had a spontaneous mutation rate increased by ~22-fold compared to wild-type cells, whereas the spontaneous mutagenesis was abolished in the mms2 rev3 double mutant. The spontaneous mutation rate in the rad9 single mutant is not significantly higher than in wild-type cells; however, the rad9∆ mutation reduced spontaneous mutagenesis seen in mms2∆ cells from 22-fold to 12-fold, and the mms2 rad9 rev3 triple mutant displayed a spontaneous mutation rate indistinguishable from that of mms2 rev3 cells (Table 2) .
These results suggest that the RAD9 gene is partially responsible for the spontaneous mutagenesis seen in the absence of MMS2, in a REV3 dependent manner.
We also determined the involvement of RAD9 in MMS-induced mutagenesis. The MMS-induced reversion of the trp1-289 allele was also elevated in the mms2 mutant, which appears to be partially suppressed by RAD9 deletion. To our surprise, while deletion of RAD9 alone only slightly reduced MMS-induced mutagenesis, we were unable to score a single revertant from the rad9 rev3 strain during the entire experiment (Table 3) . These results suggest that, like REV3, the RAD9 gene is also involved in MMS-induced mutagenesis, which is consistent with a role for RAD9 in the PRR pathway.
The DNA damage checkpoint is required for efficient PRR: Like RAD9, several other genes, such as RAD17, RAD24, DDC1 and MEC3, are also classified as G1/S and G2/M damage checkpoint genes (LONGHESE et al. 1998; SIEDE 1995) . However, it was reported that RAD9 may act in a branch alternative to the other four genes (DE LA TORRE-RUIZ et al. 1998) . In order to determine whether the above observed rad9 mutant phenotypes are unique or common to other G1/S and G2/M checkpoints, we combined a rev3 mutation with additional checkpoint mutations, such as rad17 and rad24, and compared the double mutants with corresponding single mutants. None of the rev3, rad17 or rad24 single mutants displayed a sensitivity to 0.005%
MMS on a plate assay; however, we observed a strong synergistic phenotype in the rad17 rev3
and rad24 rev3 double mutants in the same experiment (Fig. 4A,B) . Furthermore, the rad18 rad24 double mutant is no more sensitive to MMS than the rad18∆ single mutant as judged by a gradient plate assay (data not shown). These results suggest that RAD17 and RAD24 checkpoint genes participate in the PRR pathway, most likely in a manner similar to RAD9.
The RAD53 and CHK1 genes define two parallel pathways that regulate multiple cellcycle transitions (FOIANI et al. 2000) , and Rad9 is required for activation of both Rad53 and Chk1 (NAVAS et al. 1996; SANCHEZ et al. 1999) . To determine if the involvement of checkpoints in the PRR response encompassed the entire DNA damage checkpoint pathway, rad53 rev3 and chk1 rev3 double mutants were created and tested for their sensitivity to MMS on a plate assay. The rev3 mutant showed no obvious sensitivity to 0.01% MMS, and the rad53 mutant was slightly sensitive on the MMS plate. However, the rev3 rad53 double mutant was inviable on this concentration of MMS, which unmistakably shows a synergistic interaction between the two genes (Fig. 4C) . In contrast, under the same experimental conditions, the rev3 chk1 double mutant displayed a phenotype no more sensitive than the single mutants (Fig. 4D ).
These results suggest that the RAD53 branch, and not the CHK1 branch, of the checkpoint pathway is responsible for facilitating the tolerance of the DNA lesion by the PRR pathway.
The involvement of checkpoint genes and other genes in PRR was further assessed by a genome-wide synthetic genetic array (SGA) approach (TONG et al. 2001) . In this case, we utilized two alternative PRR mutants, ubc13 and rev1, instead of mms2 and rev3, and screened for lethal phenotypes with the entire yeast mutant array on both synthetic minimal medium and the minimal medium containing 0.004% MMS. As illustrated in Supplementary Fig. S1 and similar data not shown, both ubc13 and rev1 are synergistic with rad9, rad17, rad24 or ddc1
(The mec3 single mutant did not grow on the tester plate) on a minimal medium containing 0.004% MMS. In contrast, the corresponding double mutants with genes involved in other cell cycle checkpoint pathways, such as chk1, pds1, mrc1, tof1 and csm3, did not display synthetic sensitive phenotypes.
RAD9 involvement in PRR is lesion specific: DNA-damaging agents produce specific types of lesions that are detrimental to the cell at specific stages of the cell cycle. For example, UV damage causes predominantly (T<>T) dimers and (6-4) photoproducts that block replication, whereas ionizing radiation such as X-ray and γ-ray produce strand breaks (FRIEDBERG et al. 2006 ). These agents mainly induce G1/S and G2/M arrest while MMS causes S-phase delay (FRIEDBERG et al. 2006) . To determine if the synergistic effect seen in the mms2 rad9 and rev3 rad9 double mutants is specific to MMS-induced damage and thus restricted to intra S-phase of the cell cycle, the sensitivity of these mutants to UV and γ-irradiation was determined (Fig. 5 ).
When treated with UV at the given dose range, rad9, mms2 and rev3 single mutants all display sensitivity. When combining the rad9 mutation with either the mms2 or rev3 mutation the double mutants display an additive phenotype to UV-irradiation (Fig. 5A,B) , suggesting that RAD9 does not have a strong genetic interaction with either MMS2 or REV3 in response to UV irradiation.
The rad9 mutant shows more than 10-fold elevated level of sensitivity to γ-irradiation than the mms2 or rev3 single mutant. When the rad9 mutation is combined with rev3, the double mutant shows a weak additive phenotype to γ-irradiation (Fig. 5D ). In contrast, combining rad9
with the mms2 mutation resulted in a slight rescuing effect of the rad9 phenotype (Fig. 5C ). The plate-based assay showed similar results ( Supplementary Fig. S2A,B) . We also determined genetic interactions when replication is stalled due to lack of substrates and found that the mms2 rad9 and rev3 rad9 double mutants hardly displayed any additional sensitivity to hydroxyurea (HU) compared to the corresponding single mutants ( Supplementary Fig. S2C,D) . Overall, these results suggest a lack of synergistic interactions between rad9 and mms2 or rev3 with regard to UV, γ-irradiation and HU-induced killing.
DISCUSSION
All living organisms have developed sophisticated networks to deal with spontaneous and induced DNA damage and this is particularly true for eukaryotic cells, from yeast to human (FRIEDBERG et al. 2006) . PRR is one such pathway dealing with damage that escapes repair but impedes replication. Unlike most other repair pathways, PRR does not remove the replicationblocking lesion, but coordinates different bypass mechanisms to avoid cell death (BARBOUR and XIAO 2003) . To date, two subpathways have been well defined: one utilizes non-essential DNA polymerases for translesion DNA synthesis (NELSON et al. 1996a; NELSON et al. 1996b) , which is considered a mutagenic or error-prone pathway, and another is mediated by Rad5-Ubc13-Mms2 (ULRICH and JENTSCH 2000; XIAO et al. 2000) , an E2-E3 ubiquitination complex capable of poly-ubiquitinating PCNA via a non-canonical Lys63 chain (HOEGE et al. 2002; HOFMANN and PICKART 1999) . While it is conceivable that such poly-ubiquitinated PCNA promotes errorfree bypass of replication-blocking lesions, the underlying mechanism of such bypass is yet unclear (PASTUSHOK and XIAO 2004) . A recent report (ZHANG and LAWRENCE 2005) suggests that the error-free pathway employs recombination between partially replicated sister strands.
Analysis of previously reported genetic screens (LEMONTT 1971; LEMONTT 1972; PRAKASH and PRAKASH 1977) led us to believe that there are genes involved in each of the errorfree and error-prone subpathways yet to be discovered and, most importantly, there may exist an additional subpathway, since cells with simultaneous inactivation of both error-free and errorprone subpathways are significantly less sensitive to DNA-damaging agents than a rad6 or rad18 mutant thought to be defective in the entire PRR pathway (BROOMFIELD et al. 1998; XIAO et al. 1999) . In this study we adapted a synthetic lethal screen approach in an attempt to identify novel genes involved in PRR. To achieve this goal, a genetic approach was developed by supplementing the screening medium with a small dose of MMS that would not interfere with single mutant growth, but is sufficient to eliminate the double mutant growth if the two mutations are synergistic. This method allowed us to isolate genes, such as REV1 and REV3, whose mutations are known to be synergistic with mms2, as well as RAD9, which is novel and surprising. This study provides several lines of evidence suggesting the involvement of RAD9 in the PRR pathway. Firstly, quantitative analysis shows that rad9 is synergistic to both mms2 and rev3 with respect to killing by MMS. The synergistic relationship with both PRR subpathways indicates that RAD9 most likely functions as a third branch within the same pathway and is less likely to be independent of the PRR pathway. Secondly, RAD9 is partially required for the increased spontaneous mutagenesis as well as MMS-induced mutagenesis seen in the mms2 cells. This phenotype is reminiscent of REV3, which is also required for spontaneous and induced mutagenesis (LAWRENCE 1982) . Furthermore, rad9 and rev3 mutations appear to have an additive effect on MMS-induced mutagenesis, suggesting that these genes confer nonoverlapping functions in mutagenesis. Finally, we demonstrated that while rad9 is synergistic with both mms2 and rev3, it is hypostatic to rad18. Most interestingly, the level of MMS sensitivity of the mms2 rad9 rev3 triple mutant is much more sensitive than any of the corresponding double mutants and is approaching that of the rad18 single mutant. Taken together, our data are consistent with a model that PRR consists of three relatively independent branches represented by MMS2, REV3 and RAD9. We further demonstrated that each branch contains several genes as defined by previous studies, and that the combination of any two mutations from genes belonging to different branches (Fig. 6 ) generates a characteristic synergistic interaction. It is of particular interest to note that RAD9 was originally placed within the RAD6 epistasis group based on its phenotypes and genetic interactions (FRIEDBERG 1988; LAWRENCE and CHRISTENSEN 1976; MCKEE and LAWRENCE 1980) . We favor an argument that it is the damage checkpoint function that is involved in PRR because the observed genetic interaction is true for all G1/S and G2/M damage checkpoint genes, regardless of their biochemical activities. Our data support a notion that when one or both error-free and errorprone branches are inactivated, a cell cycle delay becomes increasingly important for efficient PRR; however, in the absence of RAD18 function this delay has no effect on cell survival. It is interesting to note that neither PRR nor checkpoints actually removes DNA lesions; instead, they provide tolerance mechanisms to ensure cell survival in the presence of DNA damage. Data presented in this report suggest that under certain conditions, the above two responses are coordinately regulated.
An unexpected result during this study was the differential response of yeast mutants to different DNA-damaging agents. Various reports indicate that rad6 and rad18 mutants are extremely sensitive to a broad range of DNA-damaging agents regardless of lesions produced (BROOMFIELD et al. 2001 ). It appears that the common end product handled by the PRR pathway is the replication block containing a single-stranded DNA region (BROOMFIELD et al. 2001) .
Within the PRR pathway, error-free and error-prone branches appear to deal with the same set of lesions (XIAO et al. 1999) , whereas the checkpoint response to different lesions may vary. For example, compared with mms2, the rad9 mutant appears to be less sensitive to MMS, more sensitive to UV and much more sensitive to γ-irradiation. We do not know the exact reason for the quantitative to qualitative differences in terms of genetic interactions; however, it can be speculated that in the case of UV treatment, nucleotide excision repair can efficiently remove UV-induced lesions and is probably required for the initiation of the RAD9-mediated G1 checkpoint (SIEDE et al. 1994) . During S phase, RAD30-encoded Polη can efficiently bypass T<>T dimers (JOHNSON et al. 1999) , undermining the requirement for REV3. In the case of γ-irradiation, which induces largely strand breaks, the error-free and error-prone branches of PRR may play much less critical roles than the damage checkpoint. This argument appears to be consistent with MMS-induced mutagenesis, where RAD9 favors a mutagenic bypass pathway instead of template-based error-free bypass. Alternatively, the differential contribution of RAD9, or the entire damage checkpoint pathway, is simply dependent on the nature of agents that induce delay or arrest at different cell-cycle stages.
It has been previously reported that RAD9 functions to prevent genomic instability (BARRINGTON et al. 1999; SCHIESTL et al. 1989; WEINERT and HARTWELL 1990) ; however, most reports were based on assays detecting gross genome rearrangements instead of point mutations.
In this study, we utilized a base-substitution assay and report that inactivation of Rad9 partially reduces spontaneous and MMS-induced mutagenesis. This observation is reminiscent of a report on roles of RAD9 in UV-induced mutagenesis (PAULOVICH et al. 1998 ) and the 9-1-1 checkpoint clamp (composed of Ddc1, Rad17 and Mec3) in spontaneous mutagenesis (SABBIONEDA et al. 2005) . It would be interesting to determine whether rad9 enhances gross genomic rearrangement under the same conditions. All strains marked with * are isogenic to HKY578-10A or HK-578-10D and were generated by either targeted gene deletion or genetic cross between the above strain derivatives. 
